Concepts (194)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Turkey | 23 | 2023 | 254 | 1.260 |
Why?
|
| Coronary Disease | 14 | 2016 | 5914 | 0.910 |
Why?
|
| Capacity Building | 2 | 2019 | 258 | 0.520 |
Why?
|
| Research Personnel | 3 | 2019 | 588 | 0.520 |
Why?
|
| Guideline Adherence | 1 | 2024 | 2220 | 0.460 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2013 | 52 | 0.450 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2013 | 38 | 0.440 |
Why?
|
| Hypertension | 8 | 2023 | 8540 | 0.430 |
Why?
|
| Tobacco, Smokeless | 2 | 2004 | 133 | 0.410 |
Why?
|
| Health Personnel | 2 | 2024 | 3335 | 0.380 |
Why?
|
| Needs Assessment | 1 | 2014 | 1139 | 0.310 |
Why?
|
| Diabetes Mellitus | 4 | 2022 | 5841 | 0.300 |
Why?
|
| Iodine | 1 | 2020 | 288 | 0.300 |
Why?
|
| Health Policy | 6 | 2019 | 2684 | 0.280 |
Why?
|
| Wales | 4 | 2005 | 87 | 0.250 |
Why?
|
| Chronic Disease | 2 | 2023 | 9319 | 0.240 |
Why?
|
| Cardiovascular Diseases | 9 | 2016 | 15501 | 0.240 |
Why?
|
| Somalia | 1 | 2024 | 78 | 0.240 |
Why?
|
| England | 4 | 2005 | 526 | 0.220 |
Why?
|
| Hospitals, Public | 1 | 2024 | 202 | 0.210 |
Why?
|
| Mass Spectrometry | 1 | 2020 | 2192 | 0.210 |
Why?
|
| Public Health | 2 | 2019 | 2669 | 0.200 |
Why?
|
| Overweight | 1 | 2013 | 2417 | 0.200 |
Why?
|
| Risk Factors | 21 | 2023 | 74213 | 0.180 |
Why?
|
| Policy Making | 2 | 2014 | 542 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 4 | 2022 | 12148 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2014 | 3429 | 0.160 |
Why?
|
| Obesity | 6 | 2022 | 12947 | 0.160 |
Why?
|
| Smoking | 8 | 2016 | 9053 | 0.150 |
Why?
|
| Mortality | 5 | 2016 | 2901 | 0.150 |
Why?
|
| Meta-Analysis as Topic | 1 | 2003 | 1380 | 0.150 |
Why?
|
| Sodium Chloride, Dietary | 3 | 2016 | 293 | 0.150 |
Why?
|
| Life Expectancy | 1 | 2005 | 1242 | 0.150 |
Why?
|
| Decision Support Techniques | 2 | 2014 | 1998 | 0.150 |
Why?
|
| Infection Control | 1 | 2024 | 982 | 0.140 |
Why?
|
| Adult | 23 | 2024 | 221203 | 0.130 |
Why?
|
| Female | 28 | 2024 | 392686 | 0.130 |
Why?
|
| Professional Competence | 1 | 2019 | 431 | 0.130 |
Why?
|
| Male | 28 | 2024 | 360842 | 0.130 |
Why?
|
| Age Distribution | 3 | 2005 | 2880 | 0.120 |
Why?
|
| Fatigue | 1 | 2022 | 1552 | 0.120 |
Why?
|
| Stroke | 2 | 2016 | 9758 | 0.120 |
Why?
|
| Humans | 42 | 2024 | 761572 | 0.120 |
Why?
|
| Tunisia | 4 | 2016 | 36 | 0.120 |
Why?
|
| Dyspnea | 1 | 2022 | 1347 | 0.120 |
Why?
|
| RNA, Viral | 1 | 2022 | 2846 | 0.110 |
Why?
|
| Urban Health | 2 | 2006 | 532 | 0.110 |
Why?
|
| Hemorrhagic Fever with Renal Syndrome | 1 | 2013 | 1 | 0.110 |
Why?
|
| Puumala virus | 1 | 2013 | 1 | 0.110 |
Why?
|
| Vaginal Smears | 1 | 2016 | 499 | 0.110 |
Why?
|
| Cohort Studies | 3 | 2023 | 41493 | 0.110 |
Why?
|
| Neoplasms | 1 | 2022 | 22173 | 0.110 |
Why?
|
| Middle Aged | 22 | 2024 | 220920 | 0.100 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2014 | 1722 | 0.100 |
Why?
|
| Diabetic Cardiomyopathies | 1 | 2013 | 90 | 0.100 |
Why?
|
| Mediterranean Region | 3 | 2019 | 47 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2023 | 8481 | 0.090 |
Why?
|
| Cross-Sectional Studies | 5 | 2024 | 26127 | 0.090 |
Why?
|
| Health Priorities | 1 | 2014 | 374 | 0.090 |
Why?
|
| Hypercholesterolemia | 3 | 2007 | 1141 | 0.090 |
Why?
|
| Middle East | 3 | 2019 | 231 | 0.090 |
Why?
|
| Syria | 3 | 2016 | 85 | 0.090 |
Why?
|
| Aged | 18 | 2016 | 169310 | 0.090 |
Why?
|
| Sex Distribution | 2 | 2005 | 2281 | 0.080 |
Why?
|
| Waist Circumference | 1 | 2013 | 935 | 0.080 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1475 | 0.080 |
Why?
|
| Food, Fortified | 1 | 2020 | 190 | 0.080 |
Why?
|
| Finland | 1 | 2020 | 607 | 0.080 |
Why?
|
| Health Promotion | 2 | 2014 | 2214 | 0.080 |
Why?
|
| Diabetic Angiopathies | 1 | 2013 | 803 | 0.080 |
Why?
|
| Ireland | 4 | 2012 | 170 | 0.080 |
Why?
|
| Geography | 1 | 2020 | 656 | 0.080 |
Why?
|
| Physicians, Family | 1 | 2010 | 350 | 0.070 |
Why?
|
| Models, Statistical | 3 | 2016 | 5079 | 0.070 |
Why?
|
| Models, Theoretical | 2 | 2022 | 3575 | 0.070 |
Why?
|
| Family Practice | 1 | 2010 | 512 | 0.070 |
Why?
|
| Coronary Artery Disease | 2 | 2016 | 6403 | 0.070 |
Why?
|
| Risk Reduction Behavior | 3 | 2016 | 1112 | 0.070 |
Why?
|
| Aged, 80 and over | 10 | 2016 | 58986 | 0.070 |
Why?
|
| Databases, Bibliographic | 1 | 2006 | 130 | 0.070 |
Why?
|
| Prevalence | 4 | 2022 | 15732 | 0.070 |
Why?
|
| Nutrition Surveys | 1 | 2013 | 1733 | 0.070 |
Why?
|
| Immunotherapy, Active | 1 | 2006 | 59 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 14607 | 0.060 |
Why?
|
| Time and Motion Studies | 1 | 2006 | 143 | 0.060 |
Why?
|
| Rabies | 1 | 2006 | 54 | 0.060 |
Why?
|
| Pregnant Women | 1 | 2020 | 566 | 0.060 |
Why?
|
| Mammography | 1 | 2016 | 2430 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2016 | 2598 | 0.060 |
Why?
|
| Myocardial Ischemia | 1 | 2016 | 2113 | 0.060 |
Why?
|
| Bites and Stings | 1 | 2006 | 93 | 0.060 |
Why?
|
| Health Behavior | 2 | 2007 | 2644 | 0.060 |
Why?
|
| Exercise | 2 | 2016 | 5890 | 0.060 |
Why?
|
| Cost-Benefit Analysis | 4 | 2014 | 5492 | 0.060 |
Why?
|
| Incidence | 2 | 2022 | 21355 | 0.060 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2016 | 2020 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2012 | 1376 | 0.060 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2005 | 244 | 0.060 |
Why?
|
| Young Adult | 3 | 2024 | 59255 | 0.050 |
Why?
|
| Europe | 1 | 2020 | 3422 | 0.050 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2003 | 113 | 0.050 |
Why?
|
| Smoking Cessation | 3 | 2016 | 2057 | 0.050 |
Why?
|
| Cost of Illness | 1 | 2012 | 1936 | 0.050 |
Why?
|
| Hospitalization | 1 | 2022 | 10721 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2016 | 3205 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2020 | 1615 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 3201 | 0.050 |
Why?
|
| Risk | 1 | 2013 | 9610 | 0.050 |
Why?
|
| Health Status Indicators | 1 | 2006 | 970 | 0.050 |
Why?
|
| Regression Analysis | 1 | 2020 | 6344 | 0.050 |
Why?
|
| Epidemiologic Studies | 1 | 2004 | 675 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3688 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 5872 | 0.040 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 7827 | 0.040 |
Why?
|
| Sex Factors | 1 | 2013 | 10553 | 0.040 |
Why?
|
| Body Mass Index | 2 | 2016 | 12954 | 0.040 |
Why?
|
| Laryngeal Neoplasms | 1 | 2003 | 514 | 0.040 |
Why?
|
| Exercise Therapy | 1 | 2006 | 929 | 0.040 |
Why?
|
| Hospitals, University | 1 | 2021 | 564 | 0.040 |
Why?
|
| Africa, Northern | 1 | 2019 | 86 | 0.040 |
Why?
|
| Triage | 1 | 2006 | 986 | 0.040 |
Why?
|
| Alcoholism | 1 | 2010 | 1973 | 0.040 |
Why?
|
| Contact Tracing | 1 | 2021 | 271 | 0.040 |
Why?
|
| Dietary Fats | 2 | 2016 | 1995 | 0.040 |
Why?
|
| Mouth Neoplasms | 1 | 2003 | 596 | 0.040 |
Why?
|
| Primary Prevention | 1 | 2005 | 1186 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 8075 | 0.040 |
Why?
|
| Primary Health Care | 1 | 2014 | 4686 | 0.040 |
Why?
|
| Psychometrics | 1 | 2006 | 3065 | 0.030 |
Why?
|
| Age Factors | 1 | 2013 | 18398 | 0.030 |
Why?
|
| Models, Cardiovascular | 3 | 2006 | 981 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2016 | 2426 | 0.030 |
Why?
|
| Social Security | 1 | 2016 | 101 | 0.030 |
Why?
|
| Occupational Exposure | 1 | 2006 | 1813 | 0.030 |
Why?
|
| Cholesterol | 1 | 2005 | 2904 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2006 | 10090 | 0.030 |
Why?
|
| Developing Countries | 3 | 2014 | 2885 | 0.030 |
Why?
|
| Infant | 2 | 2013 | 36192 | 0.030 |
Why?
|
| Black Sea | 1 | 2013 | 2 | 0.030 |
Why?
|
| Administrative Personnel | 1 | 2014 | 184 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20099 | 0.020 |
Why?
|
| Markov Chains | 1 | 2014 | 966 | 0.020 |
Why?
|
| Stress, Psychological | 1 | 2006 | 4481 | 0.020 |
Why?
|
| Fruit | 1 | 2016 | 1160 | 0.020 |
Why?
|
| Vegetables | 1 | 2016 | 1195 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 64684 | 0.020 |
Why?
|
| Algorithms | 1 | 2020 | 14032 | 0.020 |
Why?
|
| Developed Countries | 1 | 2012 | 449 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 54426 | 0.020 |
Why?
|
| Models, Biological | 1 | 2005 | 9469 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 21017 | 0.020 |
Why?
|
| Educational Status | 1 | 2016 | 2522 | 0.020 |
Why?
|
| Pregnancy | 1 | 2020 | 29876 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2016 | 1808 | 0.020 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 1069 | 0.020 |
Why?
|
| Time Factors | 2 | 2006 | 39970 | 0.020 |
Why?
|
| Interprofessional Relations | 1 | 2012 | 990 | 0.020 |
Why?
|
| Residence Characteristics | 1 | 2016 | 2094 | 0.020 |
Why?
|
| Emergency Service, Hospital | 1 | 2006 | 7879 | 0.020 |
Why?
|
| Rural Population | 1 | 2016 | 2285 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3810 | 0.020 |
Why?
|
| Delivery of Health Care | 2 | 2014 | 5336 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2012 | 1505 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2003 | 22176 | 0.020 |
Why?
|
| Curriculum | 1 | 2019 | 3743 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2006 | 11461 | 0.020 |
Why?
|
| Quality of Life | 1 | 2006 | 13367 | 0.020 |
Why?
|
| Life Style | 1 | 2016 | 3917 | 0.010 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 823 | 0.010 |
Why?
|
| Child | 2 | 2020 | 80156 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3188 | 0.010 |
Why?
|
| Qualitative Research | 1 | 2014 | 3023 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
| Dogs | 1 | 2006 | 3839 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 4544 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2014 | 8633 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2006 | 3416 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4920 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2014 | 4330 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2006 | 2696 | 0.010 |
Why?
|
| Urban Population | 1 | 2006 | 2036 | 0.010 |
Why?
|
| Thrombolytic Therapy | 1 | 2006 | 2064 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2010 | 3600 | 0.010 |
Why?
|
| Adolescent | 3 | 2013 | 88324 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2010 | 4016 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2010 | 4793 | 0.010 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2007 | 3245 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23741 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2006 | 15843 | 0.000 |
Why?
|
| Animals | 2 | 2013 | 168467 | 0.000 |
Why?
|
| Infant, Newborn | 1 | 2006 | 26198 | 0.000 |
Why?
|
| Risk Assessment | 1 | 2006 | 23996 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2006 | 42230 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2006 | 80646 | 0.000 |
Why?
|
Concepts
(194)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_